HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HIPPOCAMPUS MORPHOMETRY STUDY ON PATHOLOGY-CONFIRMED ALZHEIMER'S DISEASE PATIENTS WITH SURFACE MULTIVARIATE MORPHOMETRY STATISTICS.

Abstract
Alzheimer's disease (AD) is one of the most prevalent neurodegenerative diseases in elderly and the incidence of this disease is increasing with older ages. One of the hallmarks of AD is the accumulation of beta-amyloid plaques (Aβ) in human brains. Most of prior brain imaging researchers used the clinical symptom based diagnosis without the confirmation of imaging or fluid Aβ information. In this work, we study hippocampus morphometry on a cohort consisting of Aβ positive AD (N = 151) and matched Aβ negative cognitively unimpaired subjects (N = 271) with Aβ positivity determined via florbetapir PET. The brain images are obtained from publicly available Alzheimer's Disease Neuroimaging Initiative (ADNI). We compute our surface multivariate morphometry statistics from segmented hippocampus structure in structural MR images. With these features, we find statistically significant difference by using Hotelling's T2 tests. Meanwhile, we apply a patch-based analysis of sparse coding system for binary group classification and achieve an accuracy rate of 90.48%. Our results demonstrate that our surface multivariate morphometry statistics (MMS) perform better than traditional hippocampal volume measures in classification and it may be applied as a potential biomarker for distinguishing dementia due to AD from age matched normal aging individuals.
AuthorsJianfeng Wu, Jie Zhang, Jie Shi, Kewei Chen, Richard J Caselli, Eric M Reiman, Yalin Wang
JournalProceedings. IEEE International Symposium on Biomedical Imaging (Proc IEEE Int Symp Biomed Imaging) Vol. 2018 Pg. 1555-1559 (Apr 2018) ISSN: 1945-7928 [Print] United States
PMID30123414 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: